The Moderna COVID‑19 vaccine, which is sold under the brand name Spikevax, was developed by Moderna, the United States National Institute of Allergy and Infectious Diseases and the Biomedical Advanced Research and Development Authority is now considered as the most effective vaccine against coronavirus.
A new study just released by the US Centers for Disease Control and Prevention suggests that the Moderna Covid vaccine is slightly more effective than Pfizer’s or Johnson & Johnson’s vaccine in preventing hospitalization, though the gap widens substantially four months after vaccination, the CDC said.
The data, collected from nearly 3,700 people at 21 hospitals in 18 states over five months (including Montefiore in the Bronx), add to a growing body of evidence that while all the vaccines work well, the Moderna shot remains the most effective over time.
Overall, the study said, the Moderna vaccine was 93% effective at preventing hospitalization for COVID among American adults without compromised immune systems. Over the same study period (March 11-August 15), the Pfizer vaccine was 88% effective and the J&J vaccine was 71% effective.
But those were overall figures. The study also broke out effectiveness, also called VE, for the period of 14-120 days after vaccination, as well as after the 120-day mark. It was there that the numbers diverged more significantly.
The Moderna vaccine remained 92% effective against hospitalization after 120 days, but the Pfizer vaccine was down to 77% effectiveness. (There was no similar calculation for the J&J vaccine, though the CDC did note that efficacy dipped to 68% more than 28 days after vaccination.)
“Understanding differences in VE by vaccine product can guide individual choices and policy recommendations regarding vaccine boosters. All FDA-approved or authorized COVID-19 vaccines provide substantial protection against COVID-19 hospitalization,” the study authors wrote.